Home            Contact us            FAQs
    
      Journal Home      |      Aim & Scope     |     Author(s) Information      |      Editorial Board      |      MSP Download Statistics

     British Journal of Pharmacology and Toxicology


A Preliminary Oral Toxicity Studies on Pausinystalia Yohimbe

1R.U. Okolo and 2M.O. Egua
1Department of Anatomical Sciences
2Department of Pharmacology and Therapeutics, College of Health Sciences, University of Abuja, Airport Road, Abuja, Nigeria
British Journal of Pharmacology and Toxicology  2019  1:1-8
http://dx.doi.org/10.19026/bjpt.9.5986  |  © The Author(s) 2019
Received: June 11, 2016  |  Accepted: August 1, 2016  |  Published: February 25, 2019

Abstract

The oral toxicity profile of the crude aqueous stem bark extract of Pausinystalia yohimbe was studied in adult albino rats. The Up and Down method (AOT425statPgm version 1.0) for acute oral toxicity was carried out using a starting dose of 175 mg/kg body weight via the oral route. For the sub chronic study, 40 male albino rats weighing between 150-200 g, were grouped into three treatment groups and a control group with 10 rats in each group. A repeat dose oral toxicity study was conducted by daily oral dosing of 600 mg/kg body weight, 150 mg/kg body weight of extract dissolved in 1ml of 0.9% saline to groups 1 and 2, respectively and 30% powdered stem bark mixed with 70% rat chow (w/w) to group 3 and 1ml of 0.9% saline was administered to rats in the control group for 28 days. On day 29, blood samples for bioassay were collected by cardiac puncture under diethyl ether anesthesia. The LD50 estimate of the extract was calculated to be greater than 2000mg/kg body weight/oral route. The extract did not cause any significant difference in the body weight of the rats. Platelet count and White Blood Cell count (WBC) were significantly elevated across the treatment groups p<0.05. Total bilirubin was significantly higher p<0.05 in the 600 and 150mg treatment groups, while conjugated bilirubin was significantly higher in the 600 mg treatment group. Total protein was significantly lower p<0.05 in the 600mg treatment group. Aspartate Transaminase was significantly higher in all the treatment groups, while Alkaline phosphatase was significantly higher in the 600 and 150mg treatment groups, p<0.05, respectively. Alanine transaminase was significantly higher in 600 mg treatment group. Na+ was elevated significantly, p<0.05. These results suggest incipient toxicity of the extract and indicate need for morphometric toxicity study.

Keywords:

Oral toxicity, pausynistalia yohimbe, rats, treats group, extract,


References

  1. Abdulrahman, F.I., J.C. Akan, O.A. Sodipo and P.A. Onyeyili, 2010. Effect of aqueous root-bark extract of Vitex domina sweet on hematological parameters in rats. J. Am. Sci., 6(12): 8-12.
    Direct Link
  2. Adeniyi, A.A., G.S. Brindley, J.P. Pryor and D.J. Ralph, 2007. Yohimbine in the treatment of orgasmic dysfunction. Asian J. Androl., 9(3): 403-407.
    CrossRef    PMid:17486282    
  3. Akerele, O., 1987. The best of both worlds: Bringing traditional medicine up to date. Soc. Sci. Med., 24(2): 177-181.
    CrossRef    
  4. Ang, H.H., K.L. Chan, E.K. Gan and K.H. Yuen, 1997. Enhancement of sexual motivation in sexually naive male mice by Eurycoma longifolia. Int. J. Pharmacol., 35: 144-146.
    Direct Link
  5. Baker, F.I., R.E. Silverton and C.J. Pallister, 1998. Introduction to Medical Laboratory Technology. 7th Edn., Bounty Press Ltd., Nigeria, pp: 339-373.
  6. Blumenthal, M. and W.R. Brusse, 1998. The Complete German Commission E Monographs Therapeutic Guide to Herbal Medicines: Developed by a Special Expert Committee of the German Federal Institute for Drugs and Medical Devices. The American Botanical Council, Austin, TX.
  7. Bunkill, H.M., 1985. The Useful Plants of West Tropical Africa. In: Farinhes, A.D. (Ed.), Vol. 1, 2nd Edn., Royal Botanical Gardens, Kew, pp: 346-349.
  8. Burtis, C.A., E.R. Ashwood and D.E. Bruns, 2012. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. In: Bruns (Ed.), 5th Edn., Elsevier Health Sciences, London.
    PMCid:PMC3501578    
  9. Clarke, E.G.C. and M.L. Clarke, 1977. Veterinary Toxicology. Cassel and Collier Macmillan Publishers, London, pp: 268-277.
  10. Culling, C.F.A., 1974. Handbook of Histopathological and Histochemical Technique. 3rd Edn., Butterworth, London.
    PMCid:PMC1646058    
  11. Duke, J.A., 1985. Handbook of Medicinal Herbs. CRC Press, Boca Raton, FL, pp: 351.
  12. Elujoba, A.A., O.M. Odeleye and C.M. Ogunyemi, 2005. Traditional medicine development for medical and dental primary health care delivery system in Africa. Afr. J. Tradit. Complem., 2(1): 46-61.
    Direct Link
  13. Ernst, E. and M.H. Pittler, 1998. Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials. J. Urol., 159(2): 433-436.
    CrossRef    
  14. Goldberg, M.R. and D. Robertson, 1983. Yohimbine: A pharmachological probe for study of the alpha 2-adrenoreceptor. Pharmacol. Rev., 35: 143-180.
    PMid:6140686    
  15. Goldberg, M.R., A.S. Hollister and D. Robertson, 1983. Influence of yohimbine on blood pressure, autonomic reflexes and plasma catecholamines in humans. Hypertension, 5(5): 772-778.
    CrossRef    PMid:6352483    
  16. Griffith, J.G., 1964. Interlaboratory variations in the determination of acute oral LD50. Toxicol. Appl. Pharm., 6(6): 726-730.
    CrossRef    
  17. National Research Council, 2011. Guide for the Care and Use of Laboratory Animals. 8th Edn., National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, DC, US.
    Direct Link
  18. Hassan, H.M., T.E.I. Mohamed, E. Ahmed, A.E.H. Mohamed and N. Sirag, 2012. Effects of methanolic extract of Pausinystalia yohimbe bark on blood glucose level in normal fasting rats. Health, 4(12): 1225-1228.
    CrossRef    
  19. Huhner, M., 1916. A Practical Treatise on Disorders in the Sexual Function of the Male and Female. 1st Edn., F.A. Davis, Philadelphia.
  20. Ijioma, S.N., C.O. Nwosu and A.A. Nwankwo, 2015. Comparative acute toxicity and hypoglycaemic studies of five Nigerian indigenous medicinal plants namely: Acalypha wilkesiana, Pausinystalia yohimbe, Moringa oleifera, Loranthus micranthus and Telfairia occidentalis in experimentally induced hyperglycaemic rats. TLEP Int. J. Biotechnol. Agric. Environ. Res., 1(2): 1-8.
  21. Jacks, T.W., A.S. Asala and J. Priasad, 2007. Testicular enhancement activity of aqueous extract of Pausinystalia macroceras stem-bark in Wistar rats. J. Anat. Sci., 1(1): 3-6.
  22. Kashinath, K.T., 1990. Hypolipidemic effect of disulphide in rats fed high lipids diet and/or ethanol. Ph.D. Thesis, University of Bangalore.
  23. Kleinman, L.I. and J.M. Lorenz, 1989. Clinical Chemistry: Theory, Analysis and Correlation. In: Kaplan, L.A. and A.J. Pesce (Eds.), CV Mosby Co., St. Louis.
  24. Lebeouf, M., A. Cave, P. Mangeney and A. Bouquet, 1981. Alkaloids of Pausinystalia macroceras. Planta Med., 41(4): 374-378.
    CrossRef    PMid:17401858    
  25. Lipnick, R.L., J.A. Cotruvo, R.N. Hill, R.D. Bruce, K.A. Stitzel, A.P. Walker, I. Chu, M. Goddard, L. Segal, J.A. Springer and R.C. Myers, 1995. Comparison of the up-and-down, conventional LD50 and fixed-dose acute toxicity procedures. Food Chem. Toxicol., 33(3): 223-231.
    CrossRef    
  26. Mayne, P.D. and J.F. Zilva, 1994. Clinical Chemistry in Diagnosis and Treatment. 6th Edn., ELBS Publishers, E. Arnold, London, Boston, pp: 14-317.
    Direct Link
  27. Mbaya, A.W., M.M. Aliyu, C.O. Nwosu, T.N. Egbe-Nwiyi and H.A. Kumshe, 2008. Studies on the leucocytic response to experimental infection with Trypanosoma brucei and Haemonchus contortus in red fronted gazelles (Gazella rufifrons). Sahel J. Vet. Sci., 7(1): 37-45.
    Direct Link
  28. McGuffin, M., C. Hobbs, R. Upton and A. Goldberg, 1997. American Herbal Product Association's Botanical Safety Handbook. CRC Press, Boca Raton, FL, pp: 63.
  29. Morales, A., 2000. Yohimbine in erectile dysfunction: The facts. Int. J. Impot. Res., 12(Suppl. 1): S70-S74.
    CrossRef    
  30. Nakajima, H., 1987. "Inaugural Address" report of the second meeting of directors of WHO collaboration centre for traditional medicine, Beijing China. 16-20 Nov., WHO, Geneva, 4: 5-7.
  31. Riley, A.J., 1994. Yohimbine in the treatment of erectile disorder. Br. J. Clin. Pharmacol., 48(3): 133-136.
    Direct Link
  32. Sala, M., D. Braida, M.P. Leone, P. Calcaterra, S. Monti and E. Gori, 1990. Central effect of yohimbine on sexual behavior in the rat. Physiol. Behav., 47(1): 165-173.
    CrossRef    
  33. Sharabi, F.M., T.T. Daabees, M.A. El-Metwally and A.M. Senbel, 2004. Comparative effects of sildenafil, phentolamine, yohimbine and l-arginine on the rabbit corpus cavernosum. Fundam. Clin. Pharmacol., 18(2): 187-194.
    CrossRef    PMid:15066133    
  34. Tharyan, P. and G. Gopalakrishnan, 2006. Erectile dysfunction. BMJ Clin. Evid., pp: 1803.
    PMCid:PMC2907627    
  35. Tietz, N.W., E.L. Prude and O. Sirgard-Anderson, 1994. Tietz Textbook of Clinical Chemistry. In: Burtis, C.A. and E.R. Ashwood (Eds.), W.B. Saunders Company, London, pp: 1354-1374.

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.

ISSN (Online):  2044-2467
ISSN (Print):   2044-2459
Submit Manuscript
   Information
   Sales & Services
Home   |  Contact us   |  About us   |  Privacy Policy
Copyright © 2024. MAXWELL Scientific Publication Corp., All rights reserved